Alkem Laboratories Limited (NSE: ALKEM), ISIN INE540L01014 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ALKEM last traded at ₹5680.50 (+0.12%), with a 52-week range of ₹4740.65 to ₹5933.00 (as of 30 Jul 2026).
Shareholding as of Jun 2026: promoters 49.70%, FIIs 10.42%, DIIs 22.63%, mutual funds 16.71%.
EquiSense Score (ECS): 85/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.